ABO and prion disease: TC-5RW was also beneficial in animal models of prion diseases, which is consistent with our findings that TC-5RW significantly reduces AβO levels, Aβ plaques and insoluble and soluble Aβ42 contents in the brains of 5XFAD mouse model of AD.